310 related articles for article (PubMed ID: 15047033)
1. Health care and medication costs and use among older adults with heart failure.
Stroupe KT; Teal EY; Weiner M; Gradus-Pizlo I; Brater DC; Murray MD
Am J Med; 2004 Apr; 116(7):443-50. PubMed ID: 15047033
[TBL] [Abstract][Full Text] [Related]
2. Impact of restrictive prescription plans on heart failure medication use.
Thanassoulis G; Karp I; Humphries K; Tu JV; Eisenberg MJ; Pilote L
Circ Cardiovasc Qual Outcomes; 2009 Sep; 2(5):484-90. PubMed ID: 20031881
[TBL] [Abstract][Full Text] [Related]
3. Association of refill adherence and health care use among adults with hypertension in an urban health care system.
Stroupe KT; Teal EY; Tu W; Weiner M; Murray MD
Pharmacotherapy; 2006 Jun; 26(6):779-89. PubMed ID: 16716131
[TBL] [Abstract][Full Text] [Related]
4. Multinational economic evaluation of valsartan in patients with chronic heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT).
Reed SD; Friedman JY; Velazquez EJ; Gnanasakthy A; Califf RM; Schulman KA
Am Heart J; 2004 Jul; 148(1):122-8. PubMed ID: 15215801
[TBL] [Abstract][Full Text] [Related]
5. Incremental effects of concurrent pharmacotherapeutic regimens for heart failure on hospitalizations and costs.
Skrepnek GH; Abarca J; Malone DC; Armstrong EP; Shirazi FM; Woosley RL
Ann Pharmacother; 2005 Nov; 39(11):1785-91. PubMed ID: 16219900
[TBL] [Abstract][Full Text] [Related]
6. Drug copayment and adherence in chronic heart failure: effect on cost and outcomes.
Cole JA; Norman H; Weatherby LB; Walker AM
Pharmacotherapy; 2006 Aug; 26(8):1157-64. PubMed ID: 16863491
[TBL] [Abstract][Full Text] [Related]
7. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction.
Sun SX; Ye X; Lee KY; Dupclay L; Plauschinat C
Clin Ther; 2008; 30 Pt 2():2217-27. PubMed ID: 19281916
[TBL] [Abstract][Full Text] [Related]
8. Economic implications of treatment guidelines for congestive heart failure.
Shibata MC; Nilsson C; Hervas-Malo M; Jacobs P; Tsuyuki RT
Can J Cardiol; 2005 Dec; 21(14):1301-6. PubMed ID: 16341301
[TBL] [Abstract][Full Text] [Related]
9. The effects of medication supply on hospitalizations and health-care costs in patients with chronic heart failure.
Dilokthornsakul P; Chaiyakunapruk N; Nimpitakpong P; Jeanpeerapong N; Sruamsiri R
Value Health; 2012; 15(1 Suppl):S9-14. PubMed ID: 22265074
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of the prescribing of potentially inappropriate medications at ambulatory care visits by elderly patients covered by the Taiwanese National Health Insurance program.
Lai HY; Hwang SJ; Chen YC; Chen TJ; Lin MH; Chen LK
Clin Ther; 2009 Aug; 31(8):1859-70. PubMed ID: 19808145
[TBL] [Abstract][Full Text] [Related]
11. The economic burden of congestive heart failure in a managed care population.
Xuan J; Duong PT; Russo PA; Lacey MJ; Wong B
Am J Manag Care; 2000 Jun; 6(6):693-700. PubMed ID: 10977478
[TBL] [Abstract][Full Text] [Related]
12. The risk of adverse drug events and hospital-related morbidity and mortality among older adults with potentially inappropriate medication use.
Page RL; Ruscin JM
Am J Geriatr Pharmacother; 2006 Dec; 4(4):297-305. PubMed ID: 17296535
[TBL] [Abstract][Full Text] [Related]
13. The complexity and cost of drug regimens of older patients hospitalized with heart failure in the United States, 1998-2001.
Masoudi FA; Baillie CA; Wang Y; Bradford WD; Steiner JF; Havranek EP; Foody JM; Krumholz HM
Arch Intern Med; 2005 Oct; 165(18):2069-76. PubMed ID: 16216996
[TBL] [Abstract][Full Text] [Related]
14. The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease.
Ezekowitz J; McAlister FA; Humphries KH; Norris CM; Tonelli M; Ghali WA; Knudtson ML;
J Am Coll Cardiol; 2004 Oct; 44(8):1587-92. PubMed ID: 15489090
[TBL] [Abstract][Full Text] [Related]
15. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.
Ye X; Sikirica V; Schein JR; Grant R; Zarotsky V; Doshi D; Benson CJ; Riedel AA
Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274
[TBL] [Abstract][Full Text] [Related]
16. Intensity and focus of heart failure disease management after hospital discharge.
Shah MR; Flavell CM; Weintraub JR; Young MA; Hasselblad V; Fang JC; Nohria A; Lewis EF; Givertz MM; Mudge G; Stevenson LW
Am Heart J; 2005 Apr; 149(4):715-21. PubMed ID: 15990758
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease.
Berger AK; Duval S; Manske C; Vazquez G; Barber C; Miller L; Luepker RV
Am Heart J; 2007 Jun; 153(6):1064-73. PubMed ID: 17540211
[TBL] [Abstract][Full Text] [Related]
18. Merck Serono targets convenient, affordable medicines for patients at risk.
Cardiovasc J Afr; 2009; 20(1):77. PubMed ID: 19287822
[No Abstract] [Full Text] [Related]
19. A survey of outpatient management of elderly heart failure patients in Poland-treatment patterns.
Rywik TM; Rywik SL; Korewicki J; Broda G; Sarnecka A; Drewla J
Int J Cardiol; 2004 Jun; 95(2-3):177-84. PubMed ID: 15193817
[TBL] [Abstract][Full Text] [Related]
20. Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey.
Komajda M; Lapuerta P; Hermans N; Gonzalez-Juanatey JR; van Veldhuisen DJ; Erdmann E; Tavazzi L; Poole-Wilson P; Le Pen C
Eur Heart J; 2005 Aug; 26(16):1653-9. PubMed ID: 15827061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
